Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine

PDF] Chronic Rhinosinusitis with Nasal Polyps.

Biomedicines, Free Full-Text

Biomedicines, Free Full-Text

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis - Fokkens - 2023 - Allergy - Wiley Online Library

JCM, Free Full-Text

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

PDF] Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial

Mepolizumab as Anti-interleukin-5 Therapy for Chronic Rhinosinusitis with Nasal Polyposis - touchRESPIRATORY

IL-5 antagonist showed efficacy in chronic rhinosinusitis with nasal polyps - Medical Conferences

Eosinophils & MOA NUCALA (mepolizumab) for CRSwNP

Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal Polyps - ScienceDirect

Mepolizumab as Anti-interleukin-5 Therapy for Chronic Rhinosinusitis with Nasal Polyposis - touchRESPIRATORY

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study

Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial - eClinicalMedicine